TrialCancer chemotherapy and pharmacology2025

Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic metastatic breast cancer female patients: a randomized controlled trial.

Hager Salah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.